You are here:
Novartis
#

Novartis

Get Alerts

Articles

View all

To the brink and back: Key business events in 2013

Dec 31, 2013

To the brink and back: Key business events in 2013

The RBI starting the year off with rate cuts and then reversing its stance on concerns about widening current account deficit. Fears that the US Federal Reserve will start cutting its bond purchase programme sooner than expected only added to the worries. Foreign funds pulled out of the Indian equities and debt in hoards. #Infosys #Inflation #Gold #P. Chidambaram #RBI #Rupee #Ben Bernanke #Phaneesh Murthy #Narayana Murthy #WPI #US Federal Reserve #Raghuram Rajan #Tesco #Ambani #Pepsi #iGate #CPI #CAD #Jignesh Shah #Novartis #NSEL #taper #Tata Trent #RearView2013
Pharma sector registers single digit growth in 2013; regulators increase scrutiny

Dec 29, 2013

Pharma sector registers single digit growth in 2013; regulators increase scrutiny

The Indian pharma sector, estimated to be around Rs 1.5 lakh crore, recorded single digit growth for the first time in several years on account of deeper price cuts under pricing policy and selective boycott of companies by the retailers. #FDI #Cipla #Sun Pharmaceuticals #Wockhardt #Ranbaxy #Pharma #Torrent Pharmaceuticals #WTO #Biocon #gsk #Pfizer #Piramal Enterprises #USFDA #Novartis #Dr. Reddy #RearView2013 #Elder #IPAB #Zydus #Cadilla
EU fines Ranbaxy, 8 others for blocking cheaper drugs

Jun 20, 2013

EU fines Ranbaxy, 8 others for blocking cheaper drugs

The punishments follow a 2009 report by the European Commission on the pharmaceutical sector, which said "pay-for-delay" deals lead to consumers paying as much as 20 percent more for their medicines. #BreakingNow #Drugs #EU #Ranbaxy #Healthcare #Novartis
Cancer immunotherapy drugs will soon be a $35 bn global industry

May 22, 2013

Cancer immunotherapy drugs will soon be a $35 bn global industry

A new wave of medicines that tap the power of the immune system to fight cancer could become the biggest drug class in history, with potential sales of $35 billion a year. #Business #ThisisNext #science #Health #Citigroup #Cancer #GlaxoSmithKline #Merck & Co. #AstraZeneca #Novartis #Sector Spotlight #Immunotherapy drugs #Amgen
Novartis patent row: US 'concerned' over India's patent norms, innovation

May 02, 2013

Novartis patent row: US 'concerned' over India's patent norms, innovation

Raising questions over innovation climate in India, the US has said the recent decision by India's Supreme Court to prohibit patent of Novartis' cancer drug Glivec could "preclude issuance of a patent" in the country. #India #WhyNow #Drugs #Innovation #Patent #Pharma #Novartis #glivec

BLOG POSTS

View all

Why a global fight against cancer is a good idea

Apr 10, 2013

Why a global fight against cancer is a good idea

In a substantive paper published today in the journal Nature Reviews, a group of authors from Singapore, the USA and Brazil evaluate the cost of cancer medication in low and middle income countries. #WhyNow #Cancer #Healthcare #Diabetes #Novartis #glivec #Merck #Dabur Pharma

Wire

View all

Why a global fight against cancer is a good idea

Aug 18, 2014

April 2015 Options Now Available For Novartis (NVS)

Investors in Novartis (NYSE: NVS) saw new options become available today, for the April 2015 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 242 days until expiration the n... #Novartis #NYSE
Why a global fight against cancer is a good idea

Aug 20, 2014

Novartis hands over experimental TB drugs in antibiotic pullback

Novartis has signed a licensing deal to hand over its experimental tuberculosis (TB) drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma retreat from antibiotic... #Novartis #NYSE
Why a global fight against cancer is a good idea

Jul 31, 2014

What China Security Zsar Anti-Corruption Investigation Means For International Business

China's investigation of former head of security, Zhou Yongkang - at one point the third most powerful member of the Communist party - shows that China really is taking its anti-corruption investigations seriously. But what does this mean for interna... #China #Novartis #Zhou Yongkang